(consulting), Scynexis, Inc. (consulting), Tibotec BVBA (advisory arrangements), Tibotec, Inc. (consulting, advisory arrangements, research grants), Vertex Pharmaceuticals, Inc. (consulting, advisory arrangements, research grants). John G. McHutchison reports the following financial relationships: Abbott Laboratories (research grants), Anadys Pharmaceuticals (advisory arrangements, research grants), Bristol-Myers Squibb (advisory arrangements, research Selleckchem Trichostatin A grants), Gilead Sciences, Inc. (stock ownership or equity, employment), GlobeImmune, Inc. (advisory arrangements, research grants), Human Genome Sciences, Inc. (advisory arrangements, research grants), Idera Pharmaceuticals, Inc.
(advisory arrangements, research grants), LabCorp (consulting), Liver Institute for Education and Research (unrestricted grants), Medtronic, Inc. (research grants), Merck & Co., Inc. (advisory arrangements, research grants, intellectual property), Monogram Business Sciences, Inc. (advisory arrangements), Pharmasset, Inc. (consulting, research grants), Roche Laboratories (research grants), Roche Pharmaceuticals AZD3965 (research grants), Scynexis,
Inc. (consulting, research grants), Tibotec BVBA (research grants), Tibotec, Inc. (research grants), Vertex Pharmaceuticals, Inc. (consulting, advisory arrangements, research grants). Stefan Zeuzem reports the following financial relationships: Abbott Laboratories (consulting), Anadys Pharmaceuticals (consulting), Bristol-Myers Squibb (consulting, speakers’ bureau), Genentech (consulting, speakers’ bureau), Gilead Sciences, Inc. (consulting, speakers’ bureau), Human Genome Sciences, Inc. (consulting), Idera Pharmaceuticals, Inc. (consulting), Merck & Co., Inc. (consulting, speakers’ bureau), Pharmasset, Inc. (consulting), Roche Molecular Diagnostics (speakers’ bureau), Roche Pharmaceuticals (consulting, very speakers’ bureau), Tibotec BVBA (consulting),
Vertex Pharmaceuticals, Inc. (consulting). Alessandra Mangia reports the following financial relationships: Merck & Co., Inc. (research grants), Roche Pharmaceuticals (advisory arrangements), Tibotec, Inc. (advisory arrangements). Jean-Michel Pawlotsky reports the following financial relationships: Abbott Laboratories (advisory arrangements), Bristol-Myers Squibb (advisory arrangements), Gilead Sciences, Inc. (advisory arrangements, research grants), Human Genome Sciences, Inc. (advisory arrangements), Merck & Co., Inc. (advisory arrangements), Roche Molecular Diagnostics (advisory arrangements), Roche Pharmaceuticals (advisory arrangements, speakers’ bureau, travel grants), Tibotec BVBA (advisory arrangements, speakers’ bureau), Vertex Pharmaceuticals, Inc. (advisory arrangements, speakers’ bureau), Virco BVBA (advisory arrangements). Kevin V. Shianna reports the following financial relationships: Merck & Co., Inc. (intellectual property).